Bandang, Abdurahim .
HRN: 05-21-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/06/2023
08/12/2023
IVT
500mg
Q8hrs
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes